Additionally, we will highlight the importance of MARCKS as a valuable therapeutic target in blood cancers and will discuss the potential of existing strategies available to tackle MARCKS-driven blood cancers. Here, MARCKS is linked to hematopoietic and lymphoid system neoplasm.